Starpharma Holdings Limited (SPL.AX)
ASX - ASX Delayed price. Currency in AUD
Add to watchlist
At close: 04:10PM AEST
| Previous close | 0.7850 |
| Open | 0.7850 |
| Bid | 0.7550 x 334700 |
| Ask | 0.7700 x 1317400 |
| Day's range | 0.7550 - 0.8000 |
| 52-week range | 0.7250 - 1.8400 |
| Volume | |
| Avg. volume | 396,750 |
| Market cap | 307.62M |
| Beta (5Y monthly) | 1.40 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.0440 |
| Earnings date | 24 Aug 2022 - 29 Aug 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 25 Mar 1988 |
| 1y target est | N/A |
- Simply Wall St.
What Kind Of Shareholders Hold The Majority In Starpharma Holdings Limited's (ASX:SPL) Shares?
The big shareholder groups in Starpharma Holdings Limited ( ASX:SPL ) have power over the company. Insiders often own a...
- Simply Wall St.
Despite Lacking Profits Starpharma Holdings (ASX:SPL) Seems To Be On Top Of Its Debt
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
- PR Newswire
Active agent in Australian-developed nasal spray >99.5% active against the Omicron SARS-CoV-2 variant
In a major development for its VIRALEZE™ antiviral nasal spray, Starpharma (ASX: SPL) today announced that its potent antiviral agent, SPL7013, achieved the maximum possible virucidal effect against the highly transmissible Omicron variant of SARS-CoV-2.
© 2022 Yahoo. All rights reserved.
